Kcm Investment Advisors LLC Eli Lilly & CO Transaction History

Kcm Investment Advisors LLC

$2.68 Billion
Q1 2024

A detailed history of Kcm Investment Advisors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Kcm Investment Advisors LLC holds 38,191 shares of LLY stock, worth $34.6 Million. This represents 1.11% of its overall portfolio holdings.

Number of Shares

38,191

Previous 38,232 0.11%

Holding current value

$34.6 Million

Previous $22.3 Million 33.32%

% of portfolio

1.11%

Previous 0.9%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$592.2 - $792.28 $24,280 - $32,483	-41 Reduced 0.11%	38,191 $29.7 Million
Q4 2023 Feb 13, 2024	BUY	$525.19 - $619.13 $1.02 Million - $1.21 Million	1,950 Added 5.37%	38,232 $22.3 Million
Q3 2023 Nov 08, 2023	BUY	$434.7 - $599.3 $1.67 Million - $2.31 Million	3,848 Added 11.86%	36,282 $19.5 Million
Q2 2023 Aug 09, 2023	BUY	$350.74 - $468.98 $2.44 Million - $3.26 Million	6,960 Added 27.32%	32,434 $15.2 Million
Q1 2023 May 09, 2023	BUY	$310.63 - $364.82 $799,250 - $938,681	2,573 Added 11.24%	25,474 $8.75 Million

Q4 2022 Jan 31, 2023	BUY	$321.55 - $374.67 $7,074 - $8,242	22 Added 0.1%	22,901 $8.38 Million
Q3 2022 Nov 10, 2022	SELL	$296.48 - $337.87 $296 - $337	-1 Reduced -0.0%	22,879 $7.4 Million
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $408,060 - $479,123	-1,464 Reduced 6.01%	22,880 $7.42 Million
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $76,508 - $95,081	-326 Reduced 1.32%	24,344 $6.97 Million
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $46,993 - $58,319	-209 Reduced 0.84%	24,670 $6.81 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $25,705 - $31,634	-116 Reduced 0.46%	24,879 $5.75 Million
Q2 2021 Oct 21, 2021	SELL	$180.55 - $233.54 $559,885 - $724,207	-3,101 Reduced 11.04%	24,995 $5.74 Million
Q2 2021 Aug 12, 2021	BUY	$180.55 - $233.54 $475,027 - $614,443	2,631 Added 10.33%	28,096 $6.45 Million
Q1 2021 May 13, 2021	BUY	$164.32 - $212.72 $123,240 - $159,540	750 Added 3.03%	25,465 $4.76 Million
Q4 2020 Feb 19, 2021	BUY	$130.46 - $172.63 $415,645 - $549,999	3,186 Added 14.8%	24,715 $4.17 Million
Q3 2020 Nov 16, 2020	SELL	$146.22 - $169.13 $499,341 - $577,578	-3,415 Reduced 13.69%	21,529 $3.19 Million
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $63,708 - $76,672	467 Added 1.91%	24,944 $4.1 Million
Q1 2020 Apr 27, 2020	SELL	$119.05 - $147.35 $193,456 - $239,443	-1,625 Reduced 6.23%	24,477 $3.4 Million
Q4 2019 Feb 18, 2020	SELL	$106.92 - $132.43 $145,838 - $180,634	-1,364 Reduced 4.97%	26,102 $3.43 Million
Q3 2019 Nov 15, 2019	SELL	$106.79 - $116.16 $28,299 - $30,782	-265 Reduced 0.96%	27,466 $3.07 Million
Q2 2019 Aug 14, 2019	BUY	$110.79 - $129.32 $1,661 - $1,939	15 Added 0.05%	27,731 $3.07 Million
Q1 2019 May 16, 2019	SELL	$111.31 - $131.02 $131,011 - $154,210	-1,177 Reduced 4.07%	27,716 $3.6 Million
Q4 2018 Feb 12, 2019	SELL	$105.9 - $118.64 $6,354 - $7,118	-60 Reduced 0.21%	28,893 $3.34 Million
Q3 2018 Nov 07, 2018	SELL	$85.86 - $107.31 $65,597 - $81,984	-764 Reduced 2.57%	28,953 $0
Q2 2018 Aug 10, 2018	SELL	$75.7 - $86.88 $1.13 Million - $1.3 Million	-14,957 Reduced 33.48%	29,717 $2.54 Million
Q1 2018 May 09, 2018	SELL	$74.21 - $87.6 $300,327 - $354,517	-4,047 Reduced 8.31%	44,674 $3.46 Million
Q4 2017 Feb 22, 2018	SELL	$81.94 - $87.89 $253,358 - $271,755	-3,092 Reduced 5.97%	48,721 $4.12 Million
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $3.99 Million - $4.43 Million	51,813	51,813 $4.43 Million

Others Institutions Holding LLY

# of Institutions

3,719

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $860B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kcm Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kcm Investment Advisors LLC with notifications on news.

Account

Kcm Investment Advisors LLC Eli Lilly & CO Transaction History